Progenics Pharmaceuticals Inc. (PGNX) Achieves Endpoints for RELISTOR Phase III Study
Progenics Pharmaceuticals Inc., engaged in the development and commercialization of therapeutic products to treat debilitating conditions and life-threatening diseases, today…